Abstract
Objectives
Indonesia could lose as much as US$93 billions due to diabetes between 2006-2015. The prevalence of DM patients was 6.9 million people in 2010 and it is predicted to reach 11.9 million people in 2030. Preventive actions are needed related to control blood sugar and HbA1c Level. It is hypothesized that patients who monitor their blood sugar have higher probability of compliance with diets and treatments. Therefore, providing DM patients with blood glucose monitor is assumed to be able to contribute for better outcome of treatment. We conducted a quasi experiment study by providing Self-Monitoring of Blood Glucose (SMBG) for DM patients in Jakarta. The study aims to ascertain good control of diabetic which is measured by the level of reduction HbA1c.
Methods
This is a prospective quasi experiment with 24-week observation after initial insulin therapy and glucometer distribution. The study population is 120 patients with the power of 80% beta and significant level of 5% alpha. The inclusion criteria is the patient is continuously insured of supply of insulin, and having HbA1c of 9% or above, and agree to participate in study for at least for 24 week-observation.
Results
Total sample of patients finishing 24-week observation until March 2016 was 42 patients. The remaining patients are still continuous follow up that will be end by June 2016. The preliminary result of 42 patients shows that 92.9% of patients had decreased significantly in HbA1c level, while 4.8% had increased HbA1c, and 2.4% had no change in HbA1c level.
Conclusions
Self-Monitoring Blood Glucose (SMBG) program has significant impact to reduce HbA1c level and it is recommended to be provided by the National Health Insurance.
Indonesia could lose as much as US$93 billions due to diabetes between 2006-2015. The prevalence of DM patients was 6.9 million people in 2010 and it is predicted to reach 11.9 million people in 2030. Preventive actions are needed related to control blood sugar and HbA1c Level. It is hypothesized that patients who monitor their blood sugar have higher probability of compliance with diets and treatments. Therefore, providing DM patients with blood glucose monitor is assumed to be able to contribute for better outcome of treatment. We conducted a quasi experiment study by providing Self-Monitoring of Blood Glucose (SMBG) for DM patients in Jakarta. The study aims to ascertain good control of diabetic which is measured by the level of reduction HbA1c.
Methods
This is a prospective quasi experiment with 24-week observation after initial insulin therapy and glucometer distribution. The study population is 120 patients with the power of 80% beta and significant level of 5% alpha. The inclusion criteria is the patient is continuously insured of supply of insulin, and having HbA1c of 9% or above, and agree to participate in study for at least for 24 week-observation.
Results
Total sample of patients finishing 24-week observation until March 2016 was 42 patients. The remaining patients are still continuous follow up that will be end by June 2016. The preliminary result of 42 patients shows that 92.9% of patients had decreased significantly in HbA1c level, while 4.8% had increased HbA1c, and 2.4% had no change in HbA1c level.
Conclusions
Self-Monitoring Blood Glucose (SMBG) program has significant impact to reduce HbA1c level and it is recommended to be provided by the National Health Insurance.
Original language | English |
---|---|
Publication status | Published - Nov 2016 |
Event | ISPOR 19TH ANNUAL EUROPEAN CONGRESS RESEARCH ABSTRACTS - Vienna, Austria Duration: 29 Oct 2016 → 2 Nov 2016 |
Conference
Conference | ISPOR 19TH ANNUAL EUROPEAN CONGRESS RESEARCH ABSTRACTS |
---|---|
Country/Territory | Austria |
City | Vienna |
Period | 29/10/16 → 2/11/16 |